Benitec Biopharma Inc. (BNTC): Price and Financial Metrics
BNTC Price/Volume Stats
| Current price | $10.66 | 52-week high | $12.89 |
| Prev. close | $9.88 | 52-week low | $2.69 |
| Day low | $9.78 | Volume | 62,200 |
| Day high | $10.93 | Avg. volume | 45,652 |
| 50-day MA | $9.99 | Dividend yield | N/A |
| 200-day MA | $7.90 | Market Cap | 247.48M |
BNTC Stock Price Chart Interactive Chart >
Benitec Biopharma Inc. (BNTC) Company Bio
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.
BNTC Price Returns
| 1-mo | -0.28% |
| 3-mo | 17.79% |
| 6-mo | 18.18% |
| 1-year | 221.08% |
| 3-year | -80.22% |
| 5-year | -93.04% |
| YTD | 230.03% |
| 2023 | 11.76% |
| 2022 | -93.51% |
| 2021 | -12.67% |
| 2020 | -60.78% |
| 2019 | -66.00% |
Continue Researching BNTC
Want to see what other sources are saying about Benitec Biopharma LTD's financials and stock price? Try the links below:Benitec Biopharma LTD (BNTC) Stock Price | Nasdaq
Benitec Biopharma LTD (BNTC) Stock Quote, History and News - Yahoo Finance
Benitec Biopharma LTD (BNTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...